Storyboard

Weight Loss Drug Zepbound May Reduce Sleep Apnea, Eli Lilly Says

A late-stage trial of Eli Lilly’s weight loss drug Zepbound showed promising results in treating sleep apnea symptoms in obese adults, the company announced Wednesday.

Avatar - Forbes
Curated by
Forbes
    • Diabetes
    • Obesity
    • Weight Loss
    • Health
    • Ozempic
Weight Loss Drug Zepbound May Reduce Sleep Apnea, Eli Lilly Says
Continue to read
3 stories in this Storyboard
    Weight Loss Drug Zepbound May Reduce Sleep Apnea, Eli Lilly Says

    Weight Loss Drug Zepbound May Reduce Sleep Apnea, Eli Lilly Says

    This is a BETA experience. You may opt-out by clicking here 4 hours ago Trump Prosecutor Fani Willis Easily Wins Her Democratic Primary, While Judge In Georgia Case Reelected 5 hours ago Louisiana House Passes Bill Making Abortion Pills Controlled Substances—A First In The Country 5 hours ago These Are …

    MORE FROM FORBES

More stories from Diabetes